Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 796 AL 810

Protective effects of phytochemical antioxidants against neurotoxin-induced degeneration of dopaminergic neurons

Kita T, Asanuma M, Miyazaki I, Takeshima M.

J Pharmacol Sci. 2014;124(3):313-9. doi: 10.1254/jphs.13r19cp. Epub 2014 Mar 4.

The perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effects

Jones BC, Huang X, Mailman RB, Lu L, Williams RW.

J Biochem Mol Toxicol. 2014 May;28(5):191-7. doi: 10.1002/jbt.21552. Epub 2014 Mar 5.

Neuroleptic malignant-like syndrome with a slight elevation of creatine-kinase levels and respiratory failure in a patient with Parkinson's disease

Wei L, Chen Y.

Patient Prefer Adherence. 2014 Feb 27;8:271-3. doi: 10.2147/PPA.S59150. eCollection 2014.

The role of exergaming in Parkinson's disease rehabilitation: a systematic review of the evidence

Barry G, Galna B, Rochester L.

J Neuroeng Rehabil. 2014 Mar 7;11:33. doi: 10.1186/1743-0003-11-33.

Rotigotine transdermal system and evaluation of pain in patients with Parkinson's disease: a post hoc analysis of the RECOVER study

Kassubek J, Chaudhuri KR, Zesiewicz T, Surmann E, Boroojerdi B, Moran K, Ghys L, Trenkwalder C.

BMC Neurol. 2014 Mar 6;14:42. doi: 10.1186/1471-2377-14-42.

Extra-pancreatic effects of incretin-based therapies

Gallwitz B.

Endocrine. 2014 Nov;47(2):360-71. doi: 10.1007/s12020-014-0223-0. Epub 2014 Mar 7.

Mitochondria: prospective targets for neuroprotection in Parkinson's disease

Yadav A, Agarwal S, Tiwari SK, Chaturvedi RK.

Curr Pharm Des. 2014;20(35):5558-73. doi: 10.2174/1381612820666140305224545.

Subsynaptic localization of nicotinic acetylcholine receptor subunits: a comparative study in the mouse and rat striatum

Garção P, Oliveira CR, Cunha RA, Agostinho P.

Neurosci Lett. 2014 Apr 30;566:106-10. doi: 10.1016/j.neulet.2014.02.018. Epub 2014 Mar 4.

Sex differences in Parkinson's disease

Gillies GE, Pienaar IS, Vohra S, Qamhawi Z.

Front Neuroendocrinol. 2014 Aug;35(3):370-84. doi: 10.1016/j.yfrne.2014.02.002. Epub 2014 Mar 4.

Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release

Finberg JP.

Pharmacol Ther. 2014 Aug;143(2):133-52. doi: 10.1016/j.pharmthera.2014.02.010. Epub 2014 Mar 5.

Neurological and neuroimaging signs of reversible parkinsonism associated with manganese exposure

Puri BK.

Neurol India. 2014 Jan-Feb;62(1):1-2. doi: 10.4103/0028-3886.128210.

Reversal of pallidal magnetic resonance imaging T1 hyperintensity in a welder presenting as reversible parkinsonism

Han SH, Ahn SW, Youn YC, Shin HW.

Neurol India. 2014 Jan-Feb;62(1):117-8. doi: 10.4103/0028-3886.128366.

Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease (QUIP) and the QUIP-rating scale in a German speaking sample

Probst CC, Winter LM, Möller B, Weber H, Weintraub D, Witt K, Deuschl G, Katzenschlager R, van Eimeren T.

J Neurol. 2014 May;261(5):936-42. doi: 10.1007/s00415-014-7299-6. Epub 2014 Mar 9.

Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?

Buttery PC, Barker RA.

J Comp Neurol. 2014 Aug 15;522(12):2802-16. doi: 10.1002/cne.23577. Epub 2014 Apr 4.

Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease

Rodrigues TM, Jerónimo-Santos A, Outeiro TF, Sebastião AM, Diógenes MJ.

Drugs Aging. 2014 Apr;31(4):239-61. doi: 10.1007/s40266-014-0160-x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias